CogRx

0 followers


Cognition Therapeutics, Inc. is a clinical-stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.

Employees

11-50

Links

Org chart

Lisa Ricciardi

Collapse
Gilbert M. Rishton
Co-Founder and Chief Chemist
John Doyle
Chief Financial Officer
Anthony O. Caggiano
Chief Medical Officer And Head Of R&d
Anthony Caggiano
Chief Medical Officer and Head of R&D
Mary Hamby
VP, Research
Theresa Devins
Vice President Clinical Operations
Steven A. Weissman
Vice President- Head of CMC
Kelsie Mozzoni LaBarbera
Senior Manager, CMC And Program Management